JP2025072496A5 - - Google Patents

Info

Publication number
JP2025072496A5
JP2025072496A5 JP2025017181A JP2025017181A JP2025072496A5 JP 2025072496 A5 JP2025072496 A5 JP 2025072496A5 JP 2025017181 A JP2025017181 A JP 2025017181A JP 2025017181 A JP2025017181 A JP 2025017181A JP 2025072496 A5 JP2025072496 A5 JP 2025072496A5
Authority
JP
Japan
Prior art keywords
invention described
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2025017181A
Other languages
English (en)
Japanese (ja)
Other versions
JP2025072496A (ja
Filing date
Publication date
Priority claimed from US16/395,531 external-priority patent/US10758535B1/en
Application filed filed Critical
Publication of JP2025072496A publication Critical patent/JP2025072496A/ja
Publication of JP2025072496A5 publication Critical patent/JP2025072496A5/ja
Pending legal-status Critical Current

Links

JP2025017181A 2019-04-26 2025-02-04 ジスキネジア治療薬 Pending JP2025072496A (ja)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US16/395,531 US10758535B1 (en) 2019-04-26 2019-04-26 Therapeutic drug for dyskinesia
US16/395,531 2019-04-26
PCT/JP2020/017652 WO2020218487A1 (en) 2019-04-26 2020-04-24 Therapeutic drug for dyskinesia
JP2021561833A JP7695891B2 (ja) 2019-04-26 2020-04-24 ジスキネジア治療薬

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP2021561833A Division JP7695891B2 (ja) 2019-04-26 2020-04-24 ジスキネジア治療薬

Publications (2)

Publication Number Publication Date
JP2025072496A JP2025072496A (ja) 2025-05-09
JP2025072496A5 true JP2025072496A5 (enExample) 2025-10-09

Family

ID=72241591

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2021561833A Active JP7695891B2 (ja) 2019-04-26 2020-04-24 ジスキネジア治療薬
JP2025017181A Pending JP2025072496A (ja) 2019-04-26 2025-02-04 ジスキネジア治療薬

Family Applications Before (1)

Application Number Title Priority Date Filing Date
JP2021561833A Active JP7695891B2 (ja) 2019-04-26 2020-04-24 ジスキネジア治療薬

Country Status (13)

Country Link
US (3) US10758535B1 (enExample)
EP (1) EP3958972A4 (enExample)
JP (2) JP7695891B2 (enExample)
KR (1) KR20220004640A (enExample)
CN (1) CN113646045A (enExample)
AU (1) AU2020260895A1 (enExample)
BR (1) BR112021021184A8 (enExample)
CA (1) CA3137400A1 (enExample)
EA (1) EA202192928A1 (enExample)
MX (1) MX2021013070A (enExample)
PH (1) PH12021552681A1 (enExample)
SG (1) SG11202111852TA (enExample)
WO (1) WO2020218487A1 (enExample)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11559525B2 (en) * 2019-04-26 2023-01-24 Sumitomo Pharma Co., Ltd. Therapeutic drug for dyskinesia
AU2021332775A1 (en) * 2020-08-31 2023-04-27 Sumitomo Pharma Co., Ltd. Therapeutic agent for motor complications in parkinson's disease

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4507303A (en) 1981-12-22 1985-03-26 Sumitomo Chemical Company, Limited Succinimide derivatives, compositions and method of use
JPH11228414A (ja) 1998-02-06 1999-08-24 Sumitomo Pharmaceut Co Ltd タンドスピロン経皮剤
KR20100056569A (ko) * 2002-01-28 2010-05-27 교와 핫꼬 기린 가부시키가이샤 운동성 질환에 걸린 환자의 치료 방법
EP1743645A4 (en) * 2004-06-01 2012-11-14 Hisamitsu Pharmaceutical Co ADHESIVE PATCH
EP1661560B1 (en) 2004-11-22 2008-11-05 Hisamitsu Pharmaceutical Co., Inc. Transdermal patch comprising a melting point lowering agent
JP4873871B2 (ja) 2005-02-28 2012-02-08 久光製薬株式会社 粘着剤及び貼付剤
JP5243254B2 (ja) 2006-10-11 2013-07-24 久光製薬株式会社 結晶含有貼付剤
US20140243350A1 (en) 2011-07-05 2014-08-28 Contera Pharma Aps Use of serotonin receptor agonists for treatment of movement disorders
ES2654787T3 (es) * 2012-04-18 2018-02-15 Contera Pharma Aps Formulación farmacéutica disponible por vía oral adecuada para la gestión mejorada de trastornos del movimiento
CA3123710A1 (en) * 2018-12-20 2020-06-25 Contera Pharma A/S Treatment of movement disorders

Similar Documents

Publication Publication Date Title
JP2024036694A5 (enExample)
JP2024032941A5 (enExample)
JP2025041734A5 (enExample)
JP2025069142A5 (enExample)
JP2024116190A5 (enExample)
JP2024114921A5 (enExample)
JPWO2021237223A5 (enExample)
JP2022122972A5 (enExample)
JP2022184985A5 (enExample)
JP2022185040A5 (enExample)
JP2024161376A5 (enExample)
JP2023166402A5 (enExample)
JP2024026077A5 (enExample)
JP2023116477A5 (enExample)
JP2022064180A5 (enExample)
JP2020079331A5 (enExample)
JP2025090801A5 (enExample)
JP2025094038A5 (enExample)
JP2025003964A5 (enExample)
JP2024073452A5 (enExample)
JP2025098156A5 (enExample)
JP2024149687A5 (enExample)
JP2024169680A5 (enExample)
JP2025084821A5 (enExample)
JP2024099585A5 (enExample)